ALTERED YIN YANG 1/RAF-1 KINASE INHIBITORY PROTEIN RATIO AS A POSSIBLE MOLECULAR MARKER AND THERAPEUTIC TARGET IN HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Notarbartolo, M.
Giannitrapani, L. [1 ,2 ]
Poma, P.
Labbozzetta, M.
Florena, A. M. [3 ]
Porcasi, R. [3 ]
Muggeo, V. M. R. [4 ]
Sandonato, L. [5 ]
D'Alessandro, N. [1 ]
Montalto, G.
机构：
[1] Univ Palermo, Dipartimento Sci Farmacol Pietro Benigno, I-90133 Palermo, Italy
[2] Univ Palermo, Dipartimento Med Clin & Patol Emergenti, I-90133 Palermo, Italy
[3] Univ Palermo, Dipartimento Patol Umana, I-90133 Palermo, Italy
[4] Univ Palermo, Dipartimento Sci Stat & Matemat Silvio Vianelli, I-90133 Palermo, Italy
[5] Univ Palermo, Dipartimento Chirurgia Oncol, I-90133 Palermo, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2010年 / 42卷
关键词：
D O I：
10.1016/S1590-8658(10)60425-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T.N.20
引用
收藏
页码：S22 / S22
页数：1
相关论文
共 50 条
  • [41] Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha
    Shengjie Zhang
    Tingting Jiang
    Lifeng Feng
    Jie Sun
    Haiqi Lu
    Qinchuan Wang
    Min Pan
    Dongsheng Huang
    Xian Wang
    Linbo Wang
    Hongchuan Jin
    Journal of Molecular Medicine, 2012, 90 : 1069 - 1077
  • [42] Inhibition of Raf-1 protein kinase by antisense phosphorothioate oligodeoxyribonucleotide is associated with sensitization of human laryngeal squamous carcinoma cells to gamma radiation
    Soldatenkov, VA
    Dritschilo, A
    Wang, FH
    Olah, Z
    Anderson, WB
    Kasid, U
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1997, 3 (01): : 13 - 20
  • [43] RecQL1 DNA repair helicase: A potential tumor marker and therapeutic target against hepatocellular carcinoma
    Futami, Kazunobu
    Ogasawara, Sachiko
    Goto, Hideyuki
    Yano, Hirohisa
    Furuichi, Yasuhiro
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 25 (04) : 537 - 545
  • [44] Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular Carcinoma
    Xu, Weikang
    Lu, Xinyu
    Liu, Jing
    Chen, Qianhui
    Huang, Xuan
    Huang, Kuiyuan
    Liu, Hongyan
    Zhu, Wei
    Zhang, Xiaoyong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [45] Mammalian Ste20-like Kinase (Mst2) Indirectly Supports Raf-1/ERK Pathway Activity via Maintenance of Protein Phosphatase-2A Catalytic Subunit Levels and Consequent Suppression of Inhibitory Raf-1 Phosphorylation
    Kilili, Geoffrey K.
    Kyriakis, John M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (20) : 15076 - 15087
  • [46] ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma
    Qiu, Weigang
    Wu, Xinquan
    Shi, Haihong
    Liu, Bingyang
    Li, Liqiong
    Wu, Wenyi
    Lin, Jianqing
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [47] Loss of Raf-1 Kinase Inhibitory Protein Delays Early-Onset Severe Retinal Ciliopathy in Cep290rd16 Mouse
    Subramanian, Balajikarthick
    Anand, Manisha
    Khan, Naheed W.
    Khanna, Hemant
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (09) : 5788 - 5794
  • [48] Assessment of YME1L and mitofusin2 as a possible diagnostic and/or therapeutic target in hepatocellular carcinoma
    Abdel-Hamid, Nabil Mohie
    Abass, Shimaa A.
    Eldomany, Ramadan A.
    Zakaria, Sherin
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2023, 60 (01): : 43 - 54
  • [49] Ablation Of Raf-1 Kinase Inhibitory Protein (RKIP) Improves Photoreceptor Structure and Function in a Cep290-Mutant Mouse Model Of Severe Retinal Degeneration
    Subramanian, Balajikarthick
    Anand, Manisha
    Khanna, Hemant
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [50] Inhibition of the Raf-1 kinase inhibitory protein (RKIP) by locostatin induces cell death and reduces the CXCR4-mediated migration of chronic lymphocytic leukemia cells
    Crassini, Kyle
    Pyke, Tahni
    Shen, Yandong
    Stevenson, William S.
    Christopherson, Richard I.
    Mulligan, Stephen P.
    Best, Oliver Giles
    LEUKEMIA & LYMPHOMA, 2018, 59 (12) : 2917 - 2928
12345